CGTX
COGNITION THERAPEUTICS INC
NASDAQ · Healthcare · Biotechnology · US
$0.73
−0.33%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- -$0.07
- Revenue estimate
- $5.3M
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- -$0.04
- EPS estimate
- -$0.06
- Revenue actual
- —
- Revenue estimate
- $5.0M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 9
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +33.6%
- Revenue beats (12Q)
- —
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | -$0.06 | -$0.04 | Beat 36.84% | — |
| May 7, 2026 | -$0.06 | -$0.05 | Beat 16.67% | — |
| Mar 26, 2026 | -$0.06 | -$0.02 | Beat 66.67% | — |
| Nov 6, 2025 | -$0.07 | -$0.06 | Beat 14.29% | — |
| Aug 7, 2025 | -$0.12 | -$0.11 | Beat 8.33% | — |
| May 7, 2025 | -$0.12 | -$0.14 | Miss -16.67% | — |
| Mar 20, 2025 | -$0.16 | -$0.17 | Miss -6.25% | — |
| Aug 8, 2024 | -$0.22 | -$0.18 | Beat 18.18% | — |
| Nov 2, 2023 | -$0.31 | -$0.22 | Beat 29.03% | — |
| May 4, 2023 | -$0.17 | -$0.21 | Miss -23.53% | — |
| Mar 23, 2023 | -$0.49 | -$0.20 | Beat 59.18% | — |
| Nov 14, 2022 | -$0.55 | -$0.29 | Beat 47.27% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026